Panel: The State of Drug Development - Innovation, Investment, and Impact
Tue, Oct 7
|
10:00 AM - 10:45 AM
Session details:
As the biotech sector adapts to economic headwinds and scientific acceleration, today’s leaders must balance bold innovation with disciplined execution. This panel convenes top executives and investors to explore how strategic choices in R&D, funding, and partnerships are shaping the next wave of breakthrough therapies—and the companies behind them. From AI-driven pipelines to smarter capital deployment, hear how leaders are steering through disruption to drive long-term impact.
- Strategic R&D Focus: Where are leaders placing their scientific bets in 2025?
- AI & Digital Transformation: How tech is reshaping early development and clinical design.
- Capital Efficiency in Tight Markets: Surviving and thriving amid funding constraints.
- Partnering for Scale: What makes a biotech stand out for deals, M&A, and alliances?
